Skip to main content

Astemizole Pregnancy and Breastfeeding Warnings

Brand names: Hismanal

Astemizole Pregnancy Warnings

Astemizole has been assigned to pregnancy category C. Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy. Astemizole should only be given during pregnancy when there are no alternatives and benefit outweighs risk.

No increased risk to the fetus was observed among 114 women involved in a prospective, controlled, observational study.

See references

Astemizole Breastfeeding Warnings

There are no data on the excretion of astemizole into human milk. However, the molecular weight of astemizole is low enough that some passage into breast milk probably occurs.

See references

References for pregnancy information

  1. (2002) "Product Information. Hismanal (astemizole)." Janssen Pharmaceuticals
  2. Pastuszak A, Schick B, Dalimonte D, Donnenfeld A, Koren G (1996) "The safety of astemizole in pregnancy." J Allergy Clin Immunol, 98, p. 748-50

References for breastfeeding information

  1. (2002) "Product Information. Hismanal (astemizole)." Janssen Pharmaceuticals

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer